Researchers have discovered protein in the body which may aid the development of new drugs with significantly lesser side effects than existing chemotherapy for cancer patients. The details were published in the Journal of Cell Stem Cell. The study showed that the protein known as YTHDF2 is needed to trigger and sustain the disease but is not needed for healthy cells to function. This identifies YTHDF2 as a promising drug to aid cancer. Tests in blood samples donated by patients showed that the protein is abundant in cancer cells while experiments in mice found that the protein is required to
